Can-Fite BioPharma Ltd. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Can-Fite BioPharma Ltd. (CANF) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 1.26 billion shares for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2023-08-31
- 2023-06-30: Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month 1.26B shares.
- 2022-06-30: Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month 397.20M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month |
|---|---|
| 2023-06-30 | 1.26B shares 6-K · filed 2023-08-31 |
| 2022-06-30 | 397.20M shares 6-K · filed 2023-08-31 |